Bcl-XLExpression and Its Downregulation by a Novel Retinoid in Breast Carcinoma Cells
- 10 April 1997
- journal article
- research article
- Published by Elsevier in Experimental Cell Research
- Vol. 232 (1) , 17-24
- https://doi.org/10.1006/excr.1997.3509
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Retinoic acid nuclear receptor β inhibits breast carcinoma anchorage independent growthJournal of Cellular Physiology, 1995
- Combinatorial Interaction of Human bcl-2 Related Proteins: Mapping of Regions Important for bcl-2/bcl-x-s InteractionBiochemical and Biophysical Research Communications, 1995
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- Bcl-2 and Bcl-x: regulatory switches for lymphoid death and survivalImmunology Today, 1994
- Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell deathCell, 1993
- bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell deathCell, 1993
- Bcl-2 blocks apoptosis in cells lacking mitochondrial DNANature, 1993
- Identification of synthetic retinoids with selectivity for human nuclear retinoic acid receptor γBiochemical and Biophysical Research Communications, 1992
- bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytesCell, 1991
- Cloning of the Chromosome Breakpoint of Neoplastic B Cells with the t(14;18) Chromosome TranslocationScience, 1984